Encompass Health Corporation
EHC
$121.54
$0.250.21%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 494.70M | 455.70M | 422.40M | 399.50M | 376.80M |
Total Depreciation and Amortization | 308.50M | 299.60M | 291.70M | 280.60M | 280.30M |
Total Amortization of Deferred Charges | 9.70M | 9.70M | 9.50M | 9.50M | 9.50M |
Total Other Non-Cash Items | 223.70M | 215.90M | 190.90M | 187.30M | 184.30M |
Change in Net Operating Assets | 16.00M | 21.90M | 10.50M | -4.50M | 10.80M |
Cash from Operations | 1.05B | 1.00B | 925.00M | 872.40M | 861.70M |
Capital Expenditure | -666.20M | -642.50M | -655.50M | -657.70M | -622.70M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -15.90M | -10.80M | -2.20M | -700.00K | -5.80M |
Cash from Investing | -682.10M | -653.30M | -657.70M | -658.40M | -628.50M |
Total Debt Issued | 105.00M | 95.00M | 65.00M | 50.00M | 100.00M |
Total Debt Repaid | -366.00M | -336.00M | -224.70M | -95.20M | -167.70M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -83.00M | -43.20M | -35.80M | -29.40M | -12.60M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -64.90M | -62.80M | -60.70M | -60.70M | -60.70M |
Other Financing Activities | -11.50M | 16.40M | 46.60M | -50.60M | -38.80M |
Cash from Financing | -420.40M | -330.60M | -209.60M | -185.90M | -179.80M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -49.90M | 18.90M | 57.70M | 28.10M | 53.40M |